Trabectedin - Wikipedia
Trabectedin, sold under the brand name Yondelis, is an antitumor chemotherapy medication for the treatment of advanced soft-tissue sarcoma and ovarian cancer. [3] [4] The most common adverse reactions include nausea, fatigue, vomiting, constipation, decreased appetite, diarrhea, peripheral edema, dyspnea, and headache. [3] [4]
Trabectedin - NCI - National Cancer Institute
Trabectedin is approved to treat: liposarcoma or leiomyosarcoma (types of soft tissue sarcoma) that cannot be removed by surgery or has spread to other parts of the body. It is used in patients who have already been treated with anthracycline chemotherapy
Trabectedin Uses, Side Effects & Warnings - Drugs.com
Mar 15, 2024 · What is trabectedin? Trabectedin is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Trabectedin is used to treat liposarcoma, a rare type of cancer that grows in fatty tissues of the body.
YONDELIS®
YONDELIS ® (trabectedin) is indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline‑containing regimen. IMPORTANT SAFETY INFORMATION.
Doxorubicin–Trabectedin with Trabectedin Maintenance in …
Sep 4, 2024 · Combination therapy with doxorubicin and trabectedin induction, followed by trabectedin maintenance, was associated with improved overall survival and progression-free survival, as compared...
Trabectedin - Chemocare
Late Effects of Chemotherapy Treatments in Childhood, Adolescent, and Young Adult Cancer Survivors. TRABECTEDIN (tra BEK te din) treats sarcoma, a cancer that occurs in bone and connective tissues, such as fat, muscle, and blood vessels. …
Trabectedin (Yondelis) | Cancer information - Cancer Research UK
Trabectedin (Yondelis) is a chemotherapy drug. You might have it as a treatment for soft tissue sarcoma or ovarian cancer. Find out more about how you have it and the side effects.
Trabectedin - Memorial Sloan Kettering Cancer Center
Dec 12, 2022 · This information from Lexicomp ® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider.
The Role of Trabectedin in Soft Tissue Sarcoma - PMC
Trabectedin is a tetrahydroisoquinoline alkaloid derived from the Caribbean marine tunicate, Ecteinascidia turbinata, and is currently produced synthetically (Carter and Keam, 2007; Cuaves and Francesch, 2009).
Trabectedin - Macmillan Cancer Support
Trabectedin is a type of chemotherapy. It is also called Yondelis ®. It is used to treat soft tissue sarcoma. It may sometimes be used to treat other cancers. It is best to read this information with our general information about chemotherapy and the type of cancer you have.